The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD)

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

March 2, 2020

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2040

Conditions
Primary Ciliary DyskinesiaKartagener Syndrome
Trial Locations (1)

Unknown

RECRUITING

University of Bern, Bern

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bicetre Hospital

OTHER

collaborator

Centre Hospitalier Intercommunal Creteil

OTHER

collaborator

University Hospital Southampton NHS Foundation Trust

OTHER

collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

collaborator

Amsterdam UMC, location VUmc

OTHER

collaborator

University of Cyprus

OTHER

collaborator

Hacettepe University

OTHER

collaborator

Marmara University

OTHER

collaborator

Hospital Universitario La Fe

OTHER

collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

lead

University of Bern

OTHER

NCT04611516 - The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD) | Biotech Hunter | Biotech Hunter